Elavil and Ditropan drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Elavil (amitriptyline hydrochloride) and Ditropan (oxybutynin chloride). Common drug interactions include weight decreased among females and headache among males.
The phase IV clinical study analyzes what interactions people have when they take Elavil and Ditropan. It is created by eHealthMe based on reports of 203 people who take the same drugs from the FDA, and is updated regularly.
What is Elavil?
Elavil has active ingredients of amitriptyline hydrochloride. It is often used in depression. eHealthMe is studying from 20,724 Elavil users. Check the latest studies of Elavil.
What is Ditropan?
Ditropan has active ingredients of oxybutynin chloride. It is often used in urge incontinence. eHealthMe is studying from 11,799 Ditropan users. Check the latest studies of Ditropan.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
203 people who take Elavil and Ditropan together, and have interactions are studied.
What are the common drug interactions of Elavil and Ditropan, by gender? *
What are the common drug interactions of Elavil and Ditropan, by age (0-1 to 60+)? *
What are the existing conditions these people have? *
* Approximation only. Some reports may have incomplete information.
Do you take Elavil and Ditropan?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Elavil and Ditropan:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Elavil:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Ditropan:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Elavil and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Ditropan and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
- Li W, Lamichhane J, "From Heartbreak to Left Bundle Branch Block: A Case of Amitriptyline Overdose", American Journal of Therapeutics, 2017 Sep .
How the study uses the data?
The study uses data from the FDA. It is based on amitriptyline hydrochloride and oxybutynin chloride (the active ingredients of Elavil and Ditropan, respectively), and Elavil and Ditropan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Combipatch vs. Neurontin, side effect and effectiveness comparison - 6 seconds ago
- Could Novorapid cause Oxygen Saturation Decreased? - 8 seconds ago
- Could Novolog cause Skin Plaque? - 9 seconds ago
- Could Norvasc cause Hyperthyroidism Aggravated? - 20 seconds ago
- Could Remodulin cause Hepatic Mass? - 28 seconds ago
- Could Cyclophosphamide cause Pneumocystis Carinii Pneumonia? - 32 seconds ago
- Could Proscar cause Vertigo Aggravated? - 36 seconds ago
- Bupivacaine and Movement - Uncontrolled Or Slow for Men aged 60+ - 48 seconds ago
- Bupivacaine and Leg And Arm Movements - Uncontrollable for Men aged 60+ - 48 seconds ago
- Hydramine vs. Pregabalin, side effect and effectiveness comparison - 48 seconds ago